申请人:Altman Michael D.
公开号:US20140148474A1
公开(公告)日:2014-05-29
The present invention provides novel pyrimidine amines of formula I which are potent inhibitors of spleen tyrosine kinase, and are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD, rheumatoid arthritis and cancer.
本发明提供了一种新型的嘧啶胺化合物I,它们是脾脏酪氨酸激酶的有效抑制剂,并可用于治疗和预防由该酶介导的疾病,如哮喘、慢性阻塞性肺病、类风湿性关节炎和癌症。